This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Mayumi Naito: Innovator in Pharmaceutical Suspensions
Introduction
Mayumi Naito is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of drug suspensions. Her innovative work focuses on enhancing the stability and solubility of sparingly water-soluble acidic drugs.
Latest Patents
Naito holds a patent for a "Suspension of Sparingly Water-Soluble Acidic Drug." This invention pertains to a stable suspension of a nonsteroidal anti-inflammatory analgesic agent that is highly dissolvable. The suspension has a pH value ranging from 2 to 5 and includes a sparingly water-soluble acidic drug with an average particle size of 1 to 15 µm, along with a polyglycerol fatty acid ester, a water-soluble polyhydric alcohol, and water. The process for producing this suspension is characterized by the pulverization and dispersion of the components using a specialized pulverizer.
Career Highlights
Naito is associated with Taisho Pharmaceutical Co., Ltd., where she has been instrumental in advancing pharmaceutical formulations. Her work has led to improved methods for producing drug suspensions that are both effective and stable over time.
Collaborations
Throughout her career, Naito has collaborated with notable colleagues, including Kazuo Hasegawa and Toshiaki Nakajima. These partnerships have contributed to the success of her innovative projects and the advancement of pharmaceutical technology.
Conclusion
Mayumi Naito's contributions to the field of pharmaceuticals, particularly in the development of drug suspensions, highlight her role as an influential inventor. Her work continues to impact the industry positively, paving the way for more effective pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
